Alaunos Therapeutics Inc (TCRT) support and resistance · $5.6M cap
Alaunos Therapeutics Inc (TCRT) is a biotechnology company listed on NASDAQ.
This page maps Alaunos Therapeutics Inc (TCRT) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported TCRT revenue for 2026-06-30 was $0. Net income was -$2.0M. TCRT currently screens at market cap $5.6M.
TCRT currently screens at market cap $5.6M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new TCRT 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the TCRT quote page for the session range and the stock page for the full model.
Not investment advice.